Amarox Sertraline Recall Due to Packaging Error

Amarox Limited has issued a precautionary recall for one batch (V2500425) of Sertraline 100mg film-coated tablets after a patient discovered Citalopram 40mg film-coated tablets incorrectly packaged within a sealed Sertraline carton. Both medications are selective serotonin reuptake inhibitors (SSRIs) manufactured by the same company at the same facility, with the error occurring during the secondary packaging stage. The United Kingdom — Medicines and Healthcare products Regulatory Agency (MHRA) and its Chief Safety Officer, Alison Cox, have instructed healthcare professionals to cease supplying the affected batch and return stock, while advising patients to check their medication and seek medical advice if they have taken the wrong drug. Patients who accidentally take Citalopram instead of Sertraline may experience heightened serotonergic side effects such as nausea, headache, sleep changes, and mild anxiety. The United Kingdom — National Health Service provides information on both Sertraline and Citalopram, which are commonly prescribed antidepressants.